泊诺（天津）创新医药研究有限公司
Supriya Lifescience Ltd.
Country: CN CDE HIGH
🇨🇳 CDE
60
60 products shown
🇺🇸 DMF
0
0 products shown
🇪🇺 CEP
0
0 products shown
Total
60
registrations
🇨🇳 CDE 注册 (60)
| Product | CAS | Status | Reg Number |
|---|---|---|---|
| Aminocaproic Acid 氨基己酸 | 60-32-2 | Class A | Y20200000822 |
| Atomoxetine 盐酸托莫西汀 | 83015-26-3 | Class A | Y20190000315 |
| Axitinib 阿昔替尼 | 319460-85-0 | Class I | Y20210000939 |
| Bimatoprost 贝美前列素 | 155206-00-1 | Class A | Y20210000911 |
| Bromfenac Sodium 溴芬酸钠 | 91714-94-2 | Class A | Y20190021249 |
| Brompheniramine 马来酸溴苯那敏 | 86-22-6 | Class A | Y20190009061 |
| Buspirone 盐酸丁螺环酮 | 36505-84-7 | Class A | Y20210001174 |
| Cefazolin Sodium 五水头孢唑林钠 | 25953-19-9 | Class A | Y20200000437 |
| Ceftizoxime Sodium 头孢唑肟钠 | 68401-81-0 | Class A | Y20230000454 |
| Ceftizoxime Sodium 头孢唑肟钠 | 68401-81-0 | Class A | Y20180000630 |
| Chlorphenamine 马来酸氯苯那敏 | 132-22-9 | Class I | Y20190009300 |
| Ciclesonide 环索奈德 | 126544-47-6 | Class A | Y20230000978 |
| Dabigatran Etexilate 达比加群酯 | 211915-06-9 | Class I | Y20250000324 |
| Dasatinib 达沙替尼 | 302962-49-8 | Class I | Y20240001401 |
| Dasatinib 达沙替尼 | 302962-49-8 | Class I | Y20240001044 |
| Diquafosol Sodium 地夸磷索钠 | 59985-21-6 | Class A | Y20210000722 |
| Entacapone 恩他卡朋 | 130929-57-6 | Class A | Y20210000005 |
| Erlotinib 盐酸厄洛替尼 | 183321-74-6 | Class A | Y20220000140 |
| Everolimus 依维莫司 | 159351-69-6 | Class A | Y20210000196 |
| Ferric Carboxymaltose 羧基麦芽糖铁 | 98063-73-1 | Class I | Y20220000753 |
| Flomoxef Sodium 氟氧头孢钠 | 99665-00-6 | Class A | Y20220000517 |
| Flunarizine 盐酸氟桂利嗪 | 52468-60-7 | Class A | Y20220000339 |
| Fluticasone Furoate 糠酸氟替卡松 | 397864-44-7 | Class I | Y20240001391 |
| Gefitinib 吉非替尼 | 184475-35-2 | Class I | Y20240001281 |
| Haloperidol Decanoate 癸酸氟哌啶醇 | 74050-20-7 | Class A | Y20220001238 |
| Hydrochlorothiazide 氢氯噻嗪 | 58-93-5 | Class A | Y20220001274 |
| Ibrutinib 伊布替尼 | 936563-96-1 | Class I | Y20250000365 |
| Lamotrigine 拉莫三嗪 | 84057-84-1 | Class A | Y20210000596 |
| Latanoprost 拉坦前列素 | 130209-82-4 | Class A | Y20170001670 |
| Lenalidomide 来那度胺 | 191732-72-6 | Class A | Y20190021221 |
| Lenvatinib 甲磺酸仑伐替尼 | 417716-92-8 | Class I | Y20220000882 |
| Letermovir 来特莫韦 | 917389-32-3 | Class I | Y20230000163 |
| Levetiracetam 左乙拉西坦 | 102767-28-2 | Class A | Y20200001057 |
| Loratadine 氯雷他定 | 79794-75-5 | Class A | Y20190000502 |
| Loxoprofen Sodium 洛索洛芬钠 | 68767-14-6 | Class I | Y20240001168 |
| Lurasidone 盐酸鲁拉西酮 | 367514-87-2 | Class A | Y20210001149 |
| Memantine 盐酸美金刚 | - | Class A | Y20190001079 |
| Mirabegron 米拉贝隆 | 223673-61-8 | Class A | Y20200001331 |
| Misoprostol 米索前列醇-羟丙甲基纤维素 | 59122-46-2 | Class A | Y20209990033 |
| Montelukast Sodium 孟鲁司特钠 | 158966-92-8 | Class A | Y20190021354 |
| Nitrofurantoin 呋喃妥因 | 67-20-9 | Class A | Y20220000872 |
| Oseltamivir 磷酸奥司他韦 | 196618-13-0 | Class A | Y20200000772 |
| Palbociclib 帕博西尼 | 571190-30-2 | Class I | Y20220000321 |
| Pazopanib 盐酸培唑帕尼 | 444731-52-6 | Class A | Y20230000108 |
| Pazopanib 盐酸培唑帕尼 | 444731-52-6 | Class I | Y20220000323 |
| Pitavastatin Calcium 匹伐他汀钙 | 147511-69-1 | Class A | Y20190021498 |
| Potassium Clavulanate WXSH0150 | - | Class A | Y20190009114 |
| Potassium Clavulanate WXSH0150 | - | Class A | Y20190009112 |
| Potassium Clavulanate WXSH0150 | - | Class A | Y20170000939 |
| Quetiapine 富马酸喹硫平 | 111974-69-7 | Class I | Y20260000021 |
| Risperidone 利培酮 | 106266-06-2 | Class A | Y20220000375 |
| Roxadustat 罗沙司他 | 808118-40-3 | Class I | Y20240000646 |
| Sevelamer 碳酸司维拉姆 | - | Class A | Y20220000327 |
| Sirolimus 西罗莫司 | 53123-88-9 | Class A | Y20220001140 |
| Tamsulosin 盐酸坦索罗辛微丸 | 106133-20-4 | Class A | Y20200001007 |
| Teicoplanin 替考拉宁 | 61036-62-2 | Class A | Y20220000374 |
| Teneligliptin 氢溴酸替格列汀 | 760937-92-6 | Class A | Y20220000579 |
| Trazodone 盐酸曲唑酮 | 19794-93-5 | Class A | Y20210000921 |
| Vitamin K 维生素K1 | 12001-79-5 | Class I | Y20200000930 |
| Voglibose 伏格列波糖 | 83480-29-9 | Class I | Y20250000354 |
Source: cde_raw;FDA_DMF | Updated: 2026-04-09 07:23:01